Business Description
Conmed Corp
NAICS : 334510
SIC : 3845
ISIN : US2074101013
Share Class Description:
CNMD: Ordinary SharesDescription
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 1.1 | |||||
| Debt-to-EBITDA | 4.12 | |||||
| Interest Coverage | 4.2 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.13 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.5 | |||||
| 3-Year EBITDA Growth Rate | 15 | |||||
| 3-Year EPS without NRI Growth Rate | 120.9 | |||||
| 3-Year FCF Growth Rate | 24.4 | |||||
| 3-Year Book Growth Rate | 3.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 19.21 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 6.85 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.31 | |||||
| 9-Day RSI | 53.01 | |||||
| 14-Day RSI | 47.42 | |||||
| 6-1 Month Momentum % | 5.8 | |||||
| 12-1 Month Momentum % | -26.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.34 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 206.95 | |||||
| Days Sales Outstanding | 67.65 | |||||
| Days Payable | 57.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.23 | |||||
| Dividend Payout Ratio | 0.21 | |||||
| Forward Dividend Yield % | 1.23 | |||||
| 5-Year Yield-on-Cost % | 1.23 | |||||
| 3-Year Average Share Buyback Ratio | -2.1 | |||||
| Shareholder Yield % | 4.41 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.32 | |||||
| Operating Margin % | 12.74 | |||||
| Net Margin % | 7.73 | |||||
| FCF Margin % | 12.47 | |||||
| ROE % | 11.89 | |||||
| ROA % | 4.27 | |||||
| ROIC % | 5.91 | |||||
| 3-Year ROIIC % | -34.27 | |||||
| ROC (Joel Greenblatt) % | 38.56 | |||||
| ROCE % | 8.18 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.78 | |||||
| Forward PE Ratio | 13.29 | |||||
| PE Ratio without NRI | 17.5 | |||||
| Shiller PE Ratio | 57.25 | |||||
| Price-to-Owner-Earnings | 13.34 | |||||
| PS Ratio | 1.61 | |||||
| PB Ratio | 2.28 | |||||
| Price-to-Free-Cash-Flow | 12.89 | |||||
| Price-to-Operating-Cash-Flow | 11.73 | |||||
| EV-to-EBIT | 18.03 | |||||
| EV-to-Forward-EBIT | 24.24 | |||||
| EV-to-EBITDA | 12.51 | |||||
| EV-to-Forward-EBITDA | 16.5 | |||||
| EV-to-Revenue | 2.3 | |||||
| EV-to-Forward-Revenue | 3.66 | |||||
| EV-to-FCF | 18.43 | |||||
| Price-to-Projected-FCF | 1.45 | |||||
| Price-to-Median-PS-Value | 0.67 | |||||
| Earnings Yield (Greenblatt) % | 5.55 | |||||
| FCF Yield % | 7.91 | |||||
| Forward Rate of Return (Yacktman) % | -2.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CNMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Conmed Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,275.993 | ||
| EPS (TTM) ($) | 3.14 | ||
| Beta | 0.94 | ||
| Volatility % | 32.64 | ||
| 14-Day RSI | 47.42 | ||
| 14-Day ATR ($) | 2.054796 | ||
| 20-Day SMA ($) | 64.166 | ||
| 12-1 Month Momentum % | -26.29 | ||
| 52-Week Range ($) | 61.05 - 117.27 | ||
| Shares Outstanding (Mil) | 30.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Conmed Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Conmed Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Conmed Corp Frequently Asked Questions
What is Conmed Corp(CNMD)'s stock price today?
The current price of CNMD is $65.26. The 52 week high of CNMD is $117.27 and 52 week low is $61.05.
When is next earnings date of Conmed Corp(CNMD)?
The next earnings date of Conmed Corp(CNMD) is .
Does Conmed Corp(CNMD) pay dividends? If so, how much?
The Dividend Yield %  of Conmed Corp(CNMD) is 1.23% (As of Today), Highest Dividend Payout Ratio of Conmed Corp(CNMD) was 2.5. The lowest was 0.21. And the median was 0.69. The  Forward Dividend Yield % of Conmed Corp(CNMD) is 1.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers